Could a DNA-Busting enzyme ease tough asthma?
NCT ID NCT03994380
First seen Apr 25, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This small pilot study tested whether inhaling a drug called rh-DNase for 4 weeks could help people with neutrophilic asthma, a type that often doesn't respond well to standard treatments. Nineteen adults with confirmed asthma and signs of airway inflammation took part. The goal was to see if the treatment improved lung function and asthma symptom control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUTROPHILIC ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Jewish Health
Denver, Colorado, 80206, United States
Conditions
Explore the condition pages connected to this study.